Hot Features
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like d... Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.83 | -11.7897727273 | 7.04 | 7.16 | 6.1 | 482376 | 6.43096597 | CS |
| 4 | -1.83 | -22.7611940299 | 8.04 | 8.175 | 6.1 | 466693 | 7.19167838 | CS |
| 12 | -0.28 | -4.31432973806 | 6.49 | 9.535 | 6.1 | 509881 | 7.62929912 | CS |
| 26 | -0.26 | -4.01854714065 | 6.47 | 9.535 | 4.73 | 353192 | 7.0085873 | CS |
| 52 | -0.88 | -12.4118476728 | 7.09 | 9.535 | 4.73 | 286075 | 6.70356182 | CS |
| 156 | -6.29 | -50.32 | 12.5 | 13.28 | 4.345 | 214396 | 7.45384266 | CS |
| 260 | -7.89 | -55.9574468085 | 14.1 | 26.16 | 4.345 | 171381 | 8.68348387 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.